Every Form 4 that Paychex Inc (PAYX) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow PAYX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PAYX filings page.
PAYCHEX INC (PAYX) major shareholder Thomas B. Golisano reported a bona fide gift of 334 shares of common stock on September 1, 2026, made from the Cynthia A. Golisano Irrevocable Trust for which he serves as trustee, as part of a quarterly trust distribution. The filing also reports that he continues to hold 35,653,923 PAYCHEX common shares directly and 37,884 shares indirectly through the trust. No Rule 10b5-1 trading plan is reported for these transactions, and the gift does not represent an open-market sale.
PAYCHEX INC executive Christopher C. Simmons reported the disposition of 130 shares of common stock on 2026-08-14 at $122.02 per share, with the footnote stating these shares were withheld to satisfy tax withholding obligations from the vesting of restricted stock units. Following this tax-withholding event, he directly holds 3,290 shares of common stock. He also reports multiple outstanding stock options over PAYX common stock, including options covering 4,391 shares at a $115.00 exercise price expiring in 2032 and 4,589 shares at a $120.86 exercise price expiring in 2033, along with several additional grants at exercise prices between $110.00 and $140.68 with expirations from 2033 to 2036.
Paychex Inc chairman and director Martin Mucci reported a bona fide gift of 9,309 shares of common stock on 2026-07-17, valued at $113.9819 per share, to The Mucci Family Foundation. After this gift, he directly holds 434,891.3318 common shares plus multiple outstanding stock option awards.
Paychex Inc. director Joseph Doody reported an internal reallocation of holdings on 2026-07-20. He transferred 164 directly held common shares to the Joseph G. Doody Revocable Living Trust, leaving 725 shares in his direct ownership and 23,922 shares held indirectly through that trust. The transfer was recorded at $0.00 per share, indicating no open-market trade.
Doody also reports indirect ownership of 1,000 Paychex shares held by the Margaret Weiss Doody Revocable Living Trust. In addition, he holds several stock options over Paychex common stock, with exercise prices between $73.53 and $140.68 and expiration dates extending from 2029 to 2035.
Paychex Sr. VP and CFO Robert L. Schrader reported selling 2,600 shares of Paychex common stock on July 20, 2026 at $115.09 per share, leaving him with 18,547 directly held shares. He also reports multiple outstanding employee stock options on Paychex common stock with exercise prices including $73.53, $112.67, $115.00, $120.86, $117.98, $121.63 and $140.68, expiring between 2030 and 2036, plus 339 shares held indirectly via a 401(k) plan.
Paychex Inc President and CEO John B. Gibson reported equity changes on 2026-07-15. He received 14318 restricted stock units, subject to vesting, and a stock option for 96971 shares at $110.0000. 14083 shares were disposed of at $110.0000 to satisfy tax withholding obligations, leaving 67048 common shares held directly, plus multiple outstanding stock option grants.
Paychex Chief Product Officer Ryan Norman Bergstrom reported equity compensation changes on July 15, 2026. He was awarded restricted stock units covering 3,409 shares, subject to vesting, under the Amended and Restated 2002 Stock Incentive Plan and a stock option for 23,088 shares with an exercise price of $110.00 expiring July 14, 2036. To satisfy tax withholding from RSU vesting, 303 shares were withheld at $110.00. After these transactions he directly owns 44,688 shares of Paychex common stock and holds options over 14,767 shares at an exercise price of $140.68 expiring July 14, 2035, in addition to the new grant.
Paychex VP and Chief HR Officer Mason Argiropoulos reported new equity awards. On July 15, 2026, he was granted 2,182 restricted stock units for common stock and 14,777 stock options with a $110 exercise price. To satisfy tax withholding from vesting restricted stock units, 386 shares were withheld, leaving 3,037 common shares held directly, alongside employee stock purchase plan and stock option positions.
Paychex Inc. senior vice president Chad C. Parodi reported equity compensation changes. He received 2,727 restricted stock units, subject to vesting, and a new stock option for 18,471 shares at $110.00, exercisable beginning 2027-07-15 and expiring 2036-07-14. To cover taxes on vesting RSUs, 300 shares were withheld at $110.00, leaving him with 8,763 common shares held directly, plus multiple outstanding stock option awards.
Paychex VP, Controller & Treasurer Christopher C. Simmons sold 2,615 shares of common stock at $115.92 on July 17, 2026, leaving 3,420 shares held directly. On July 15, he received 1,818 restricted stock units under the Amended and Restated 2002 Stock Incentive Plan, with 1,172 shares withheld to satisfy related tax obligations, and was granted 11,082 stock options at a $110.00 exercise price exercisable from July 15, 2027 to July 14, 2036.
Adam Brooks Ante, Sr. Vice President, Paycor at Paychex, Inc., received equity awards and had shares withheld for taxes. He was granted 3,409 restricted stock units, subject to vesting, and stock options over 23,088 shares at an exercise price of $110.00 per share, exercisable from July 15, 2027 to July 14, 2036. Separately, 299 shares were disposed of at $110.00 per share to satisfy tax withholding obligations arising from restricted stock unit vesting. He now directly holds 55,975 common shares and also holds stock options over 14,767 shares at $140.68 per share expiring July 14, 2035.
PAYCHEX INC Chief Legal Officer and Secretary Prabha S. Bhandari reported a Form 4 transaction involving common stock and stock options. 282 shares of common stock were disposed of at $110.00 per share to satisfy tax withholding obligations upon the lapse of restrictions on restricted stock units, leaving 1,664 common shares held directly. The filing also reports outstanding stock options covering 7,383 shares of common stock at an exercise price of $140.68 expiring on July 14, 2035, and options over 7,558 shares at $121.63 expiring on July 14, 2034.
Paychex Sr. Vice President Elizabeth Roaldsen reported a tax-withholding disposition of 2,383 shares of common stock on July 15, 2026 at $110.0000 per share, to satisfy tax withholding obligations arising from lapse of restrictions applicable to restricted stock units, leaving 6,952 shares of directly owned stock. She also holds stock options for 11,518 shares at an exercise price of $140.6800 expiring July 14, 2035 and for 14,291 shares at $121.6300 expiring July 14, 2034, with additional option grants reported.
Paychex Inc. Sr. VP & CFO Robert L. Schrader reported equity compensation activity on 2026-07-15, including an award of 4,364 shares of common stock in the form of restricted stock units and a grant of 29,553 stock options with a 110.0000 per-share exercise price expiring 2036-07-14.
To satisfy tax obligations from vesting, 2,382 shares of common stock were withheld at 110.0000 per share. After these reported transactions, he directly held 21,147 common shares and indirectly held 339 shares through a 401(k), in addition to several earlier stock option awards.
PAYCHEX INC chairman and director Martin Mucci exercised stock options to acquire 214,482 shares of common stock at $57.24 per share. On July 14, 2026, he delivered 163,329 shares to pay the exercise price or tax liability and sold 25,000 shares of common stock in open-market transactions at a weighted-average price of $109.93, with trades ranging from $109.55 to $110.225. Following these transactions, he held 444,200.3318 shares of common stock directly and retained multiple stock option grants, including 195,428 underlying shares at an exercise price of $73.53 expiring on July 14, 2030.
PAYCHEX INC senior executive Adam Brooks Ante reported a routine tax-related share disposition. On the non-derivative side, 2,678 shares of Common Stock were transferred at $102.71 per share to cover tax withholding obligations tied to vesting of restricted stock and restricted stock units. This was not an open-market sale. After this transaction, he directly holds 52,865 shares of Common Stock.
The filing also shows a Stock Option award over 14,767 underlying shares of Common Stock with an exercise price of $140.68 per share and an expiration date of July 14, 2035. These options remain outstanding as a direct holding.
Paychex Chief Product Officer Ryan Bergstrom reported routine share activity related to equity compensation. On the reported date, 2,090 shares of Paychex common stock were disposed of at $102.71 per share to satisfy tax withholding obligations arising from the vesting of restricted stock and restricted stock units. After this tax-withholding disposition, Bergstrom directly holds 41,582 shares of Paychex common stock. The filing also shows he holds a stock option covering 14,767 shares of common stock with an exercise price of $140.68 per share, expiring on July 14, 2035.
Paychex Inc. director Joseph M. Tucci reported an option exercise and related share transactions. He exercised 10,220 stock options at $60.59 per share as they approached their 10-year expiration. Of the resulting shares, 6,313 were withheld to cover tax obligations and 3,907 were sold in open-market transactions at a weighted-average price of $98.25 per share. Following these transactions, Tucci directly owned 67,364 shares of Paychex common stock.
PAYCHEX INC ten percent owner Thomas B. Golisano reported a routine change in holdings on Common Stock. A Cynthia A. Golisano Irrevocable Trust, for which he serves as trustee, made a bona fide gift transfer of 1,032 shares at a reference price of $96.98 per share as part of a quarterly distribution. Following this transaction, Golisano’s direct ownership remained large at 35,653,923 shares, and the trust’s indirect holdings reported for him were 38,218 shares.
PAYCHEX INC Sr. Vice President Elizabeth Roaldsen sold 459 shares of common stock at $90.00 per share on May 13, 2026, leaving 9,335 shares directly owned.
She also holds multiple stock option awards over 11,518, 14,291, 2,119 and 12,164 underlying shares with exercise prices between $117.98 and $140.68, expiring from 2033 to 2035.
PAYCHEX INC director Joseph M. Velli reported a routine options exercise. He exercised stock options covering 10,220 shares of common stock at an exercise price of $60.59 per share, described as options approaching their 10-year expiration date. Following the exercise, he directly holds 89,564 shares of PAYCHEX common stock.
He continues to hold multiple stock option awards on PAYCHEX common stock, with exercise prices ranging from $57.20 to $140.68 and expiration dates between 2027 and 2035. The filing shows an option exercise but no reported open-market sale of shares.
PAYCHEX INC major shareholder Thomas B. Golisano reported a bona fide gift of 109,300 shares of Paychex common stock on May 6, 2026. The shares were gifted to various non-profit organizations. Following the gift, he held 35,653,923 shares directly and 39,250 shares indirectly through the Cynthia A. Golisano Irrevocable Trust.
PAYCHEX INC major shareholder Thomas B. Golisano reported a bona fide gift of 163,930 shares of common stock on May 4, 2026, described as a gift of shares to various non-profit organizations. The shares were valued at $93.21 each for reporting purposes.
After the gift, Golisano directly holds 35,763,223 shares of Paychex common stock and indirectly holds 39,250 shares through the Cynthia A. Golisano Irrevocable Trust U/A dated June 13, 2005. The filing shows a charitable transfer rather than an open-market sale or purchase.
Paychex Inc VP and Chief HR Officer Mason Argiropoulos reported a routine tax-withholding transaction related to equity compensation. On April 15, 2026, 79 shares of Paychex common stock were disposed of at $90.26 per share to satisfy tax withholding obligations from the vesting of restricted stock units. After this non‑market disposition, Argiropoulos directly holds 3,423 shares of common stock.
The filing also lists outstanding stock options over Paychex common stock, including options on 1,006 shares at an exercise price of $122.45 expiring on April 14, 2034, options on 11,909 shares at $121.63 expiring on July 14, 2034, and options on 11,075 shares at $140.68 expiring on July 14, 2035. The Employee Stock Purchase Plan balance is reported as 199.5 shares as of March 31, 2026.
PAYCHEX INC senior vice president Adam Brooks Ante reported a routine tax-related share disposition. On the lapse of restrictions on restricted stock and restricted stock units, 2,249 shares of common stock were withheld on April 1, 2026 at $90.91 per share to cover tax obligations, leaving him with 55,543 directly held shares.
He also continues to hold stock options covering 14,767 shares of common stock with an exercise price of $140.68 per share, expiring on July 14, 2035. The filing shows no open‑market purchases or sales, only tax withholding and existing option holdings.
PAYCHEX INC Chief Product Officer Ryan Norman Bergstrom reported a routine share withholding related to equity compensation. On the reported date, 1,374 shares of common stock were disposed of at $90.91 per share to satisfy tax withholding obligations from vesting restricted stock and restricted stock units. This was not an open-market trade but a mechanism to cover taxes.
After this tax withholding, Bergstrom directly holds 43,672 shares of PAYCHEX common stock. He also has outstanding stock options covering 14,767 underlying shares at a strike price of $140.68 per share, expiring in 2035, indicating a continuing long-term equity position.
Paychex Inc. insider Thomas B. Golisano reported a bona fide gift of 1,104 shares of Common Stock at $93.65 per share. The shares were transferred by the Cynthia A. Golisano Irrevocable Trust, for which he serves as trustee, as a quarterly distribution. After this transaction, his indirect holdings through the trust were 39,250 shares, and his directly owned Common Stock holdings were 35,927,153 shares, reflecting a correction of previously overstated gift amounts.
Paychex Inc. director Joseph Doody reported an indirect purchase of Paychex common stock through the Margaret Weiss Doody Revocable Living Trust. On February 4, 2026, the trust bought 1,000 shares of common stock at $98.76 per share and now holds 1,000 shares.
Separate from this trade, Doody is shown as directly holding 889 shares of Paychex common stock and indirectly holding 23,758 shares through the Joseph G. Doody Revocable Living Trust. He also holds multiple stock option awards with various exercise prices and expirations extending through 2035.
Paychex, Inc. director Tom Bonadio reported buying 1,000 shares of Paychex common stock on February 4, 2026 at $98.498 per share. After this purchase, he directly owns 21,504 common shares.
The disclosure also lists multiple stock option grants held directly, with exercise prices between $57.20 and $140.68, and individual grants covering between 670 and 9,615 underlying Paychex common shares, with expiration dates running through 2035.
Paychex Inc. insider Thomas B. Golisano, a more than 10% owner, reported a charitable stock gift. On 01/30/2026 he gifted 26,130 shares of Paychex common stock, reported at a price of $102.13 per share, to various non-profit organizations.
After this transaction, he beneficially owned 35,917,763 shares of Paychex common stock directly. In addition, 40,354 shares were held indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dated 6/13/2005.
Paychex Inc. 10% owner Thomas B. Golisano reported a charitable stock gift. On January 23, 2026, he made a gift of 9,390 shares of Paychex common stock, coded as transaction type “G,” at a reported price of $107.17 per share. The filing notes this was a gift of shares to various non-profit organizations.
After this transaction, Golisano directly beneficially owned 35,943,893 shares of Paychex common stock. He also had 40,354 shares held indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dated June 13, 2005. The filing reflects an ongoing, very large ownership position despite the gifted shares.
Paychex, Inc. insider transaction: Major shareholder Thomas B. Golisano, identified as a 10% owner of Paychex, reported a charitable gift of 239,845 shares of Common Stock on January 21, 2026. The transaction used code G, indicating a bona fide gift, at a reference price of $107.77 per share, and the filing notes the shares were gifted to various non-profit organizations.
Following this transaction, Golisano beneficially owned 35,953,283 shares of Paychex common stock directly and 40,354 shares indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dated June 13, 2005.
Paychex, Inc. executive Chad C. Parodi, SVP, HCM, PEO & Insurance, reported a small disposition of company stock tied to equity compensation. On 01/15/2026, 347 shares of Paychex common stock were withheld at $110.51 per share to satisfy tax withholding obligations arising from the lapse of restrictions on restricted stock units. After this tax-related share disposition, Parodi beneficially owned 6,336 shares of Paychex common stock directly. He also held stock options exercisable for 6,775, 13,192, and 11,813 shares of common stock with exercise prices of $119.72, $121.63, and $140.68, respectively, all held directly.
Paychex (PAYX) insider reported a charitable gift of common stock. On 10/28/2025, the reporting person executed a Code G transaction, gifting 200 shares at $123.87 per share. Following the transaction, the filer beneficially owns 36,640,384 shares directly and 41,277 shares indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005. The filer is identified as a Director and filed individually.
Paychex (PAYX) director reported a charitable transfer of common stock. On 10/22/2025, the insider filed a Code G transaction indicating a gift of 302,050 shares to various non-profit organizations.
After the transaction, the filer reported 36,640,584 shares beneficially owned directly and 41,277 shares owned indirectly through the Cynthia A. Golisano Irrevocable Trust U/A dtd 6/13/2005.
Paychex Inc. (PAYX) reported an insider Form 4 for a senior vice president. On 10/15/2025, the officer disposed of 41 common shares at $127.52 under code F, which indicates shares were withheld to cover taxes from vested restricted stock units.
After the transaction, the officer beneficially owned 9,794 shares, held directly. The filing also lists vested and unvested stock options, including 12,164 shares at an exercise price of $120.86 (expiring 07/14/2033) and 14,291 shares at $121.63 (expiring 07/14/2034).
Paychex (PAYX) reported an insider equity award on Form 4. A director acquired 725 shares of common stock via restricted stock units on 10/15/2025 at $0, increasing beneficial ownership to 79,344 shares directly.
The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, first exercisable on 10/15/2026 and expiring on 10/14/2035. Existing option holdings remain outstanding across multiple grants, with exercise prices ranging from $57.20 to $140.68 and expirations extending through 2035. The RSU award is pursuant to the Amended and Restated 2002 Stock Incentive Plan.
Paychex, Inc. (PAYX) disclosed an insider equity award. A director reported acquiring 725 shares of common stock on 10/15/2025 at $0, reflecting vested or granted shares. Following the transaction, the director beneficially owned 11,770 shares directly.
The filer also received a stock option grant for 3,061 shares at an exercise price of $127.52, exercisable 10/15/2026 and expiring 10/14/2035. The filing notes the equity award includes restricted stock units subject to vesting under the company’s Amended and Restated 2002 Stock Incentive Plan.
Paychex (PAYX) reported an insider transaction by its Sr. VP & CFO. On 10/15/2025, the officer disposed of 116 shares of common stock at $127.52 under code F, a sale to cover taxes from the vesting of restricted stock units. Following the transaction, the officer beneficially owns 19,165 shares directly and 322 shares indirectly via a 401(k). The filing also lists outstanding stock options across multiple grants with various exercise prices and expirations.
Paychex (PAYX) disclosed a director’s equity awards on Form 4. The reporting person acquired 725 shares of common stock at $0, noted as restricted stock units subject to vesting. The filing also reports a new stock option grant for 3,061 shares at $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Following the transaction, 3,951 shares of common stock were beneficially owned directly.
Paychex (PAYX) reported an insider equity award on a Form 4. A director acquired 725 shares of common stock on 10/15/2025 at $0, noted as an award of restricted stock units subject to vesting under the Amended and Restated 2002 Stock Incentive Plan. Following the transaction, the insider beneficially owned 20,504 shares, held directly.
The filing also lists a new stock option grant for 3,061 shares at an exercise price of $127.52 on 10/15/2025, exercisable 10/15/2026 and expiring 10/14/2035. Additional previously granted options with various strike prices and expirations remain outstanding.
Paychex (PAYX) — Form 4 insider activity: A company director reported equity awards dated 10/15/2025. The filing shows 725 shares of common stock acquired at $0, reflecting settlement of restricted stock units under the Amended and Restated 2002 Stock Incentive Plan. Following this, beneficial ownership stands at 67,364 shares, held directly.
The director also reported a new stock option grant for 3,061 shares at an exercise price of $127.52, granted on 10/15/2025, exercisable starting 10/15/2026 and expiring on 10/14/2035. The filing lists additional previously granted options with exercise prices and expirations on a rolling schedule.
Paychex, Inc. (PAYX) filed a Form 4 showing a director received an equity grant on 10/15/2025. The filing reports the award of 725 restricted stock units at a price of $0, pursuant to the Amended and Restated 2002 Stock Incentive Plan.
The director also received a new stock option for 3,061 shares with an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035. Following these transactions, the director beneficially owned 2,800 shares directly. The filing also lists previously awarded options, including 5,082 at $120.86 (expiring 07/14/2033), 3,351 at $121.63 (expiring 07/14/2034), and 670 at $140.68 (expiring 07/14/2035).
Paychex (PAYX) Form 4: A director reported equity awards on 10/15/2025. The filing shows an award of 725 shares of common stock at a price of $0, noted as restricted stock units subject to vesting. Following this, 889 shares were beneficially owned directly, and 23,758 shares were beneficially owned indirectly through the Joseph G. Doody Revocable Living Trust. A stock option for 3,061 shares was granted at an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035.
Paychex (PAYX) reported an insider transaction by its President and CEO. On 10/15/2025, the executive disposed of 624 shares of common stock at $127.52 per share, coded “F”.
According to the footnote, the shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units. Following the transaction, the executive directly holds 81,131 shares of Paychex common stock.
Paychex (PAYX) reported insider activity. A reporting person who is a Director and Chairman received 855 restricted stock units on 10/15/2025 at a price of $0 under the Amended and Restated 2002 Stock Incentive Plan. The person also received a stock option for 3,607 shares with an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035.
Following these transactions, the filer reported 426,324.3318 shares beneficially owned, held directly. The filing also lists previously granted option awards with various exercise prices and expiration dates.
Paychex (PAYX) reported an insider Form 4 for a company officer (VP, Controller & Treasurer). On 10/15/2025, the officer disposed of 38 shares of common stock at $127.52 under code F, reflecting shares withheld to cover taxes from restricted stock units vesting. Following this transaction, the officer beneficially owns 5,389 shares directly.
The filing also lists outstanding stock options, including 7,310 options at an exercise price of $140.68 (exercisable 07/15/2026; expiration 07/14/2035).
Paychex Inc. (PAYX) director reported equity awards. On 10/15/2025, the insider acquired 725 shares of common stock at $0, described as an award of restricted stock units subject to vesting. Following this, the insider beneficially owned 8,254 shares directly. The filing also shows a new stock option grant for 3,061 shares at an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035, alongside previously granted options with various terms.
Adam Brooks, identified as Sr. Vice President, Paycor and an officer of Paychex Inc. (PAYX), reported a transaction dated 10/01/2025 in which he disposed of 8,902 shares of Paychex common stock at a price of $124.01. The filing states this disposition was to satisfy tax withholding obligations arising from the lapse of restrictions on restricted stock/RSUs. After the sale Mr. Brooks beneficially owns 59,603 shares. The Form 4 also shows Mr. Brooks holds 14,767 stock options with an exercise price of $140.68, exercisable beginning 07/15/2026 and expiring 07/14/2035.
Paychex Inc. (PAYX) reporting person Ryan Norman Bergstrom, Chief Product Officer, disposed of 6,781 shares of Paychex common stock on 10/01/2025 at a price of $124.01 per share to satisfy tax withholding arising from the lapse of restricted stock/RSU restrictions. After the disposition the reporting person beneficially owns 46,484 shares directly. The filing also shows a stock option position with a $140.68 exercise price covering 14,767 underlying shares that become exercisable on 07/15/2026 and expire on 07/14/2035. The Form 4 was executed by an attorney-in-fact on 10/03/2025.